Laboratory-based studies showed that host immune genes could influence the prognosis of non-small-cell lung cancer (NSCLC). Therefore, genetic polymorphisms in host immune genes may serve as predictors for NSCLC clinical outcome. To test the hypothesis that functional single nucleotide polymorphisms (SNPs) in host immune genes are associated with the prognosis of NSCLC, we systematically performed a genotyping analysis for a total of 178 SNPs from 52 immune genes in a prospective case cohort of 568 NSCLC patients. Among the 178 SNPs, 24 were significantly associated with NSCLC prognosis in different genetic models and four of them were remained in the final predictive model after multivariate stepwise Cox regression, including IL-5R rs11713419 (5 0 -untranslated region, 5 0 -UTR) (P 5 0.001), IL23R rs6682925 (5 0 -flanking region, 5 0 -FR) (P 5 0.017), TLR1 rs5743551 (5 0 -FR) (P 5 0.02) and TLR3 rs3775291 (Leu412Phe) (P 5 0.01). We then put the above four SNPs together, and found that the risk of death was significantly increased by 124% (HR 5 2.24, 95% CI: 1.33-3.75) for the patients carrying ''1'' unfavorable locus and by 175% (HR 5 2.75, 95% CI: 1.67-4.51) for those carrying ''2-4'' unfavorable loci. The risk score model and time-dependent ROC analyses further support the four SNPs and clinical risk score model. The area under curve (AUC) at year 5 increased from 0.484 to 0.831 after combining the four SNPs risk score with clinical risk score. These findings indicate that potentially functional polymorphisms in immune genes may serve as prognostic markers of clinical outcome of NSCLC.There are continuous improvements to our understanding of the molecular connections of immune response and inflammation with cancer development and progression. A regulated adaptive immune response is antitumorigenic, whereas an unrestrained innate or inappropriate adaptive response may lead to chronic inflammation and a protumorigenic environment. 1 Cytokines and their receptors play an essential role in regulation of the host immunity and could act as potential autocrine or paracrine factors for cancer initiation and/or progression. The expression of cytokines and their respective receptors appear to influence cell proliferation, differentiation, and movement of both tumor and stromal cells, regulate communications between tumor and stroma, and interactions between tumor and the extracellular matrix. 2 Toll-like receptors (TLRs) have emerged as a key component of the innate immune system that recognizes a wide variety of pathogen-